BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Fierbinteanu-Braticevici C, Dina I, Petrisor A, Tribus L, Negreanu L, Carstoiu C. Noninvasive investigations for non alcoholic fatty liver disease and liver fibrosis. World J Gastroenterol 2010; 16(38): 4784-4791 [PMID: 20939106 DOI: 10.3748/wjg.v16.i38.4784]
URL: https://www.wjgnet.com/1007-9327/full/v16/i38/4784.htm
Number Citing Articles
1
John Richard, Ildiko Lingvay. Hepatic steatosis and Type 2 diabetes: current and future treatment considerationsExpert Review of Cardiovascular Therapy 2011; 9(3): 321 doi: 10.1586/erc.11.15
2
Cassiano Pozzati, Wellington Martins. [Diagnostic aspects of non alcoholic fatty liver disease] Aspectos diagnósticos da esteatose hepática não alcóolicaExperts in Ultrasound: Reviews and Perspectives 2011; 3(2): 54 doi: 10.4281/eurp.2011.02.05
3
Iradj Maleki, Mahmood Reza Aminafshari, Tarang Taghvaei, Vahid Hosseini, Alireza Rafiei, Zhila Torabizadeh, Maryam Barzin, Elahe Orang. Serum immunoglobulin A concentration is a reliable biomarker for liver fibrosis in non-alcoholic fatty liver diseaseWorld Journal of Gastroenterology 2014; 20(35): 12566-12573 doi: 10.3748/wjg.v20.i35.12566
4
Llorenç Caballería Rovira, Irfan Majeed, Alba Martínez Escudé, Ingrid Arteaga Pillasagua, Pere Torán Monserrat. Esteatosis hepática: diagnóstico y seguimientoFMC - Formación Médica Continuada en Atención Primaria 2017; 24(7): 378 doi: 10.1016/j.fmc.2017.03.001
5
Y.H. Yen, F.Y. Kuo, C.C. Lin, C.L. Chen, K.C. Chang, M.C. Tsai, T.H. Hu. Predicting Hepatic Steatosis in Living Liver Donors Via Controlled Attenuation ParameterTransplantation Proceedings 2018; 50(10): 3533 doi: 10.1016/j.transproceed.2018.06.039
6
Fulvio Cacciapuoti, Anna Scognamiglio, Rossella Palumbo, Raffaele Forte, Federico Cacciapuoti. Silymarin in non alcoholic fatty liver diseaseWorld Journal of Hepatology 2013; 5(3): 109-113 doi: 10.4254/wjh.v5.i3.109
7
Rodrigo Bremer Nones, Cláudia Pontes Ivantes, Maria Lucia Alves Pedroso. Can FIB4 and NAFLD fibrosis scores help endocrinologists refer patients with non-alcoholic fat liver disease to a hepatologist?Archives of Endocrinology and Metabolism 2017; 61(3): 276 doi: 10.1590/2359-3997000000233
8
Ahmed O. Almobarak, Salma Barakat, Eltayeb A. Suliman, Wadie M. Elmadhoun, Nabeel A. Mohamed, Israa O. Abobaker, Sufian K. Noor, Sarra O. Bushara, Mohamed H. Ahmed. Prevalence of and predictive factors for nonalcoholic fatty liver disease in Sudanese individuals with type 2 diabetes: Is metabolic syndrome the culprit?Arab Journal of Gastroenterology 2015; 16(2): 54 doi: 10.1016/j.ajg.2015.06.001
9
Tamara Milovanovic Alempijevic, Milica Stojkovic Lalosevic, Igor Dumic, Nevena Jocic, Aleksandra Pavlovic Markovic, Sanja Dragasevic, Ivana Jovicic, Snezana Lukic, Dragan Popovic, Tomica Milosavljevic. Diagnostic Accuracy of Platelet Count and Platelet Indices in Noninvasive Assessment of Fibrosis in Nonalcoholic Fatty Liver Disease PatientsCanadian Journal of Gastroenterology and Hepatology 2017; 2017: 1 doi: 10.1155/2017/6070135
10
Bruna Z. Schild, Luciano Neto Santos, Márcia Keller Alves. Nonalcoholic fatty liver disease and its association with metabolic syndrome in the preoperative period in patients undergoing bariatric surgeryRevista da Associação Médica Brasileira (English Edition) 2013; 59(2): 155 doi: 10.1016/S2255-4823(13)70449-1
11
Ciarán P Fisher, Andrzej M Kierzek, Nick J Plant, J Bernadette Moore. Systems biology approaches for studying the pathogenesis of non-alcoholic fatty liver diseaseWorld Journal of Gastroenterology 2014; 20(41): 15070-15078 doi: 10.3748/wjg.v20.i41.15070
12
Mohsen Razavizade, Raika Jamali, Abbas Arj, Hamidreza Talari. Serum parameters predict the severity of ultrasonographic findings in non-alcoholic fatty liver diseaseHepatobiliary & Pancreatic Diseases International 2012; 11(5): 513 doi: 10.1016/S1499-3872(12)60216-1
13
Álvaro Terán Lantarón, Javier Crespo García. Cribado de la enfermedad hepática por depósito de grasa: cómo y a quiénGastroenterología y Hepatología 2011; 34(4): 278 doi: 10.1016/j.gastrohep.2010.11.010
14
S. A. Pavlovskyi. EVALUATION OF CONTENT OF CITOKINS IN PATIENTS� BLOOD WITH NON-ALCOHOLIC STEATOHEPATITIS COMBINED WITH DIABETES MELLITUS TYPE 2 UNDER THE INFLUENCE OF COMBINED SUCTIONAL THERAPYBulletin of Problems Biology and Medicine 2018; (144): 170 doi: 10.29254/2077-4214-2018-1-2-143-170-175
15
Llorenç Caballería, Joan Saló, Annalisa Berzigotti, Ramón Planas, Carme Vila, Carlos Huertas, Miquel Torres, Pere Torán, Joan Caballería. Hígado graso no alcohólico. Documento de posicionamiento de la Societat Catalana de DigestologiaGastroenterología y Hepatología 2014; 37(6): 372 doi: 10.1016/j.gastrohep.2014.03.005
16
Earl Kim, Yunkoo Kang, Seungmin Hahn, Mi Jung Lee, Young Nyun Park, Hong Koh. The efficacy of aspartate aminotransferase-to-platelet ratio index for assessing hepatic fibrosis in childhood nonalcoholic steatohepatitis for medical practiceKorean Journal of Pediatrics 2013; 56(1): 19 doi: 10.3345/kjp.2013.56.1.19
17
Mariana V. Machado, Helena Cortez-Pinto. Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisalJournal of Hepatology 2013; 58(5): 1007 doi: 10.1016/j.jhep.2012.11.021
18
Amir H. Davarpanah, Jeffrey C. Weinreb. The Role of Imaging in Hepatocellular CarcinomaJournal of Clinical Gastroenterology 2013; 47(Supplement 1): S7 doi: 10.1097/MCG.0b013e31827f0d3d
19
Isabel C. Hernández-Osorio, Marco Antonio Luján-Ramos. Aspectos relevantes de la enfermedad por hígado graso no alcohólicoHepatología 2021; : 310 doi: 10.52784/27112330.137
20
Paolo Ricchi, Antonella Meloni, Silvia Costantini, Anna Spasiano, Tiziana Di Matola, Alessia Pepe, Patrizia Cinque, Aldo Filosa. Soluble form of transferrin receptor-1 level is associated with the age at first diagnosis and the risk of therapeutic intervention and iron overloading in patients with non-transfusion-dependent thalassemiaAnnals of Hematology 2017; 96(9): 1541 doi: 10.1007/s00277-017-3057-z
21
Li‐Kun Zhong, Guo Zhang, Shuang‐Yan Luo, Wu Yin, Huai‐Yu Song. The value of platelet count in evaluating the degree of liver fibrosis in patients with chronic hepatitis BJournal of Clinical Laboratory Analysis 2020; 34(7) doi: 10.1002/jcla.23270
22
Pirjo Käkelä, Tuomo Rantanen, Hannu Paajanen, Kirsi A Virtanen. Fatal complications after an interrupted gastric bypass operation in a patient with non-alcoholic fatty liver disease and massive obesity: a case reportJournal of Surgical Case Reports 2021; 2021(6) doi: 10.1093/jscr/rjab247
23
Tannaz Eslamparast, Sareh Eghtesad, Hossein Poustchi, Azita Hekmatdoost. Recent advances in dietary supplementation, in treating non-alcoholic fatty liver diseaseWorld Journal of Hepatology 2015; 7(2): 204-212 doi: 10.4254/wjh.v7.i2.204
24
Silvia I. Mora, Jonathan García-Román, Iván Gómez-Ñañez, Rebeca García-Román. Chronic liver diseases and the potential use of S-adenosyl-l-methionine as a hepatoprotectorEuropean Journal of Gastroenterology & Hepatology 2018; 30(8): 893 doi: 10.1097/MEG.0000000000001141
25
Maria Franzini, Irene Fornaciari, Vanna Fierabracci, Hassan Aziz Elawadi, Valeria Bolognesi, Simona Maltinti, Angelo Ricchiuti, Nicola Bortoli, Santino Marchi, Alfonso Pompella, Claudio Passino, Michele Emdin, Aldo Paolicchi. Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liver diseaseLiver International 2012; 32(4): 629 doi: 10.1111/j.1478-3231.2011.02673.x
26
Mehran Rahimlou, Hoda Ahmadnia, Azita Hekmatdoost. Dietary supplements and pediatric non-alcoholic fatty liver disease: Present and the futureWorld Journal of Hepatology 2015; 7(25): 2597-2602 doi: 10.4254/wjh.v7.i25.2597
27
Mona Hegazy, Soheir Abo-Elfadl, Abeer Mostafa, Magdy Ibrahim, Laila Rashed, Ahmed Salman. Serum Resistin Level and Its Receptor Gene Expression in Liver Biopsy as Predictors for the Severity of Nonalcoholic Fatty Liver DiseaseEuroasian Journal of Hepato-Gastroenterology 2014; 4(2): 59 doi: 10.5005/jp-journals-10018-1102
28
D. A. Miles, C. S. Levi, J. Uhanova, S. Cuvelier, K. Hawkins, G. Y. Minuk. Pocket-Sized Versus Conventional Ultrasound for Detecting Fatty Infiltration of the LiverDigestive Diseases and Sciences 2020; 65(1): 82 doi: 10.1007/s10620-019-05752-x
29
Geum-Youn Gwak. Diagnosis of Non-alcoholic Fatty Liver DiseaseThe Journal of Korean Diabetes 2014; 15(2): 82 doi: 10.4093/jkd.2014.15.2.82
30
Anastasia Asimakopoulou, Ralf Weiskirchen. Lipocalin 2 in the pathogenesis of fatty liver disease and nonalcoholic steatohepatitisClinical Lipidology 2015; 10(1): 47 doi: 10.2217/clp.14.65
31
Yong Jiang, Tao Han, Zhi-Guang Zhang, Ying Zhang, Feng-Xiang Qi. Serum thymosin beta4 as a noninvasive biomarker in patients with nonalcoholic steatohepatitisRevista Española de Enfermedades Digestivas 2017; 110 doi: 10.17235/reed.2017.4690/2016
32
Bruna Z. Schild, Luciano Neto Santos, Márcia Keller Alves. Doença hepática gordurosa não alcoólica e sua relação com a síndrome metabólica no pré-operatório de pacientes submetidos à cirurgia bariátricaRevista da Associação Médica Brasileira 2013; 59(2): 155 doi: 10.1016/j.ramb.2012.10.004
33
Sabine Siegert, Zhonghao Yu, Rui Wang-Sattler, Thomas Illig, Jerzy Adamski, Jochen Hampe, Susanna Nikolaus, Stefan Schreiber, Michael Krawczak, Michael Nothnagel, Ute Nöthlings, Erica Villa. Diagnosing Fatty Liver Disease: A Comparative Evaluation of Metabolic Markers, Phenotypes, Genotypes and Established BiomarkersPLoS ONE 2013; 8(10): e76813 doi: 10.1371/journal.pone.0076813
34
Su-Mei Li, Guang-Xia Li, Dong-Mei Fu, Yu Wang, Li-Qun Dang. Liver fibrosis evaluation by ARFI and APRI in chronic hepatitis CWorld Journal of Gastroenterology 2014; 20(28): 9528-9533 doi: 10.3748/wjg.v20.i28.9528
35
Xing-Xi Gao, Da-Hua Shi, Yun-Xi Chen, Jiang-Tao Cui, Yu-Rong Wang, Chun-Ping Jiang, Jun-Hua Wu. The therapeutic effects of tectorigenin on chemically induced liver fibrosis in rats and an associated metabonomic investigationArchives of Pharmacal Research 2012; 35(8): 1479 doi: 10.1007/s12272-012-0819-y
36
Dongsub Jeon, Minkook Son, Juhyun Shim. Dynamics of Serum Retinol and Alpha-Tocopherol Levels According to Non-Alcoholic Fatty Liver Disease StatusNutrients 2021; 13(5): 1720 doi: 10.3390/nu13051720
37
Kai-Lun Shih, Wei-Wen Su, Chia-Chu Chang, Chew-Teng Kor, Chen-Te Chou, Ting-Yu Chen, Hung-Ming Wu. Comparisons of parallel potential biomarkers of 1H-MRS-measured hepatic lipid content in patients with non-alcoholic fatty liver diseaseScientific Reports 2016; 6(1) doi: 10.1038/srep24031
38
Maëna Le Corvec, Coralie Allain, Salim Lardjane, Thibault Cavey, Bruno Turlin, Alain Fautrel, Karima Begriche, Valérie Monbet, Bernard Fromenty, Patricia Leroyer, Pascal Guggenbuhl, Martine Ropert, Olivier Sire, Olivier Loréal. Mid-infrared fibre evanescent wave spectroscopy of serum allows fingerprinting of the hepatic metabolic status in miceThe Analyst 2016; 141(22): 6259 doi: 10.1039/C6AN00136J
39
Nitin Kapoor, Jennifer Audsley, Priscilla Rupali, Joe Sasadeusz, Thomas V. Paul, Nihal Thomas, Sharon R. Lewin. A gathering stormAIDS 2019; 33(7): 1105 doi: 10.1097/QAD.0000000000002161
40
Anastasia Asimakopoulou, Sabine Weiskirchen, Ralf Weiskirchen. Lipocalin 2 (LCN2) Expression in Hepatic Malfunction and TherapyFrontiers in Physiology 2016; 7 doi: 10.3389/fphys.2016.00430
41
Dimitrios G Bouzianas, Stella D Bouziana, Apostolos I Hatzitolios. Potential treatment of human nonalcoholic fatty liver disease with long-chain omega-3 polyunsaturated fatty acidsNutrition Reviews 2013; 71(11): 753 doi: 10.1111/nure.12073